SE8305866L - Heterocykliska foreningar och forfaranden for deras framstellning - Google Patents

Heterocykliska foreningar och forfaranden for deras framstellning

Info

Publication number
SE8305866L
SE8305866L SE8305866A SE8305866A SE8305866L SE 8305866 L SE8305866 L SE 8305866L SE 8305866 A SE8305866 A SE 8305866A SE 8305866 A SE8305866 A SE 8305866A SE 8305866 L SE8305866 L SE 8305866L
Authority
SE
Sweden
Prior art keywords
compounds
cycloalkyl
image
treatment
procedures
Prior art date
Application number
SE8305866A
Other languages
English (en)
Other versions
SE8305866D0 (sv
Inventor
A J Crame
A D Borthwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8305866D0 publication Critical patent/SE8305866D0/sv
Publication of SE8305866L publication Critical patent/SE8305866L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SE8305866A 1982-10-25 1983-10-25 Heterocykliska foreningar och forfaranden for deras framstellning SE8305866L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8230379 1982-10-25

Publications (2)

Publication Number Publication Date
SE8305866D0 SE8305866D0 (sv) 1983-10-25
SE8305866L true SE8305866L (sv) 1984-04-26

Family

ID=10533819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305866A SE8305866L (sv) 1982-10-25 1983-10-25 Heterocykliska foreningar och forfaranden for deras framstellning

Country Status (18)

Country Link
US (1) US4496579A (sv)
JP (1) JPS5998086A (sv)
KR (1) KR840006486A (sv)
AU (1) AU2055283A (sv)
BE (1) BE898072A (sv)
CH (1) CH661046A5 (sv)
DE (1) DE3338753A1 (sv)
ES (1) ES8504200A1 (sv)
FI (1) FI833887A (sv)
FR (1) FR2534921B1 (sv)
GB (1) GB2129795B (sv)
GR (1) GR79405B (sv)
IL (1) IL70034A0 (sv)
IT (1) IT1212893B (sv)
LU (1) LU85059A1 (sv)
NL (1) NL8303673A (sv)
SE (1) SE8305866L (sv)
ZA (1) ZA837921B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
GB8410459D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Chemical compounds
PT80344B (pt) * 1984-04-24 1987-09-30 Glaxo Group Ltd Processo para a preparacao de compostos tetra-hidrobenzodioxinopirrole
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
DE10107243A1 (de) * 2001-02-16 2002-08-22 Bayer Ag Benzodioxinopyrrole, deren Herstellung und Verwendung
US20070078569A1 (en) * 2005-09-30 2007-04-05 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20070074921A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the appendages of a user
US8099200B2 (en) 2005-09-30 2012-01-17 Coombs Joshua D Vehicle interface based on the weight distribution of a user
US20070074922A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the torso of a user
US20090076686A1 (en) * 2005-09-30 2009-03-19 Jeffrey Schox Vehicle interface to communicate a safety alert mode command

Also Published As

Publication number Publication date
SE8305866D0 (sv) 1983-10-25
LU85059A1 (fr) 1985-06-19
GB2129795A (en) 1984-05-23
CH661046A5 (fr) 1987-06-30
GB2129795B (en) 1986-02-12
IT1212893B (it) 1989-11-30
FR2534921B1 (fr) 1987-01-16
IT8349214A0 (it) 1983-10-25
GB8328468D0 (en) 1983-11-23
FI833887A0 (fi) 1983-10-25
IL70034A0 (en) 1984-01-31
FR2534921A1 (fr) 1984-04-27
ES526738A0 (es) 1985-04-16
DE3338753A1 (de) 1984-04-26
ES8504200A1 (es) 1985-04-16
US4496579A (en) 1985-01-29
BE898072A (fr) 1984-04-25
ZA837921B (en) 1985-04-24
KR840006486A (ko) 1984-11-30
GR79405B (sv) 1984-10-22
JPS5998086A (ja) 1984-06-06
FI833887A (fi) 1984-04-26
NL8303673A (nl) 1984-05-16
AU2055283A (en) 1984-05-03

Similar Documents

Publication Publication Date Title
SE8305866L (sv) Heterocykliska foreningar och forfaranden for deras framstellning
DK623586A (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
BR8403068A (pt) Compostos,processo para sua preparacao,composicoes farmaceuticas e uso dos ditos compostos
KR950032267A (ko) 11,21-비스페닐-19-노르프레그난 유도체
KR890002121A (ko) 신규 벤조피란 유도체, 그의 제조방법 및 이를 함유하는 제약학적 조성물
ES8207152A1 (es) Un procedimiento para la preparacion de imidazolilfenilamidinas.
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
AU8696182A (en) 1-phenyl-2-aminocarbonylindole compounds
ZA815043B (en) Diazepine derivatives,process for their preparation,and pharmaceutical compositions thereof
HUT42440A (en) Process for preparing novel indole-carboxamide derivatives and pharmaceutical compositions comprising such compounds
ATE16804T1 (de) Pyrid-3-yl oder piperidin-3-yl-indolon-derivate, ihre salze, verfahren zur herstellung, zusammensetzungen die sie enthalten und die verwendung als heilmittel.
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
DK156064C (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
CS402491A3 (en) Heterocyclic amino compounds, process for their preparation andpharmaceutical compositions containing thereof
DK154891C (da) Analogifremgangsmaade til fremstilling af thieno-thiazolderivater og deres fysiologisk acceptable syreadditionssalte.
DE3560945D1 (en) Aminoalcohols, process for their preparation and medicaments containing these compounds and intermediates
JPS56150002A (en) Nonaprenylamine derivative
ATE8786T1 (de) Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
AU564457B2 (en) Phlorophenone derivatives
HUT35670A (en) Process for preparing indole derivatives and pharmaceutical compositions containing sucg compounds
HUT36469A (en) Process for producing 2-/n-pyrrolidino/-3-isobuthyloxy-n-/substituted phenyl/-n-benzyl-propyl-amines and acid additional salts thereof
SU1355128A3 (ru) Способ получени пиперазинсодержащих производных алкилтиола или алкилтиокарбамата или их солей
ES8407023A1 (es) Un procedimiento para la preparacion de 4-(3-trifluormetilfenil-1,2,3,6-tetrahidropiridinas
ES482581A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas.
ES8501382A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305866-9

Effective date: 19851011